White Paper: Oligonucleotides - Opportunities, Pipeline and ChallengesAlthough meaningful progress toward the development of oligonucleotide therapeutics began in the 1970s, nearly a half century later, only three oligonucleotide drugs have been approved by the FDA....

read more